Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-453065
Filing Date
2012-11-06
Accepted
2012-11-06 06:21:02
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398726d10q.htm 10-Q 702632
2 EX-31.1 d398726dex311.htm EX-31.1 9819
3 EX-31.2 d398726dex312.htm EX-31.2 9858
4 EX-32.1 d398726dex321.htm EX-32.1 5680
  Complete submission text file 0001193125-12-453065.txt   3960358

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mapp-20120930.xml EX-101.INS 578296
6 XBRL TAXONOMY EXTENSION SCHEMA mapp-20120930.xsd EX-101.SCH 28816
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mapp-20120930_cal.xml EX-101.CAL 46557
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mapp-20120930_def.xml EX-101.DEF 96633
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mapp-20120930_lab.xml EX-101.LAB 260639
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mapp-20120930_pre.xml EX-101.PRE 187634
Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Filer) CIK: 0001401923 (see all company filings)

EIN.: 200507047 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-33719 | Film No.: 121181689
SIC: 2834 Pharmaceutical Preparations